Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Road, Atlanta, GA 30322, USA.
School of Nursing, Columbia University, New York, NY 10032, USA.
Psychoneuroendocrinology. 2020 Oct;120:104793. doi: 10.1016/j.psyneuen.2020.104793. Epub 2020 Jul 6.
Postpartum depression (PPD) is a significant mental health concern, especially for women in vulnerable populations. Oxytocin (OT), a hormone essential for a variety of maternal tasks, including labor, lactation, and infant bonding, has also been hypothesized to have a role in postpartum depression. Women are routinely given synthetic oxytocin to induce or augment labor and to prevent postpartum hemorrhage. The aim of this study was to review the quality and reliability of literature that examines potential relationships between OT and PPD to determine if there is sufficient data to reliably assess the strength of these relationships. We conducted a literature search in December of 2018 using five databases (PubMed, Web of Science, Embase, PsycInfo, and CINAHL). Eligible studies were identified, selected, and appraised using the Newcastle-Ottawa quality assessment scale and Cochrane Collaboration's tool for assessing risk of bias, as appropriate. Sixteen studies were included in the analysis and broken into two categories: correlations of endogenous OT with PPD and administration of synthetic OT with PPD. Depressive symptoms were largely measured using the Edinburgh Postnatal Depression Scale. OT levels were predominately measured in plasma, though there were differences in laboratory methodology and control of confounders (primarily breast feeding). Of the twelve studies focused on endogenous oxytocin, eight studies suggested an inverse relationship between plasma OT levels and depressive symptoms. We are not able to draw any conclusions regarding the relationship between intravenous synthetic oxytocin and postpartum depression based on current evidence due to the heterogeneity and small number of studies (n = 4). Considering limitations of the current literature and the current clinical prevalence of synthetic OT administration, we strongly recommend that rigorous studies examining the effects of synthetic OT exposure on PPD should be performed as well as continued work in defining the relationship between endogenous OT and PPD.
产后抑郁症(PPD)是一个严重的心理健康问题,尤其是在弱势群体的女性中。催产素(OT)是一种对各种产妇任务至关重要的激素,包括分娩、哺乳和婴儿依恋,也被假设在产后抑郁症中起作用。女性通常会被给予合成催产素来诱导或增强分娩并预防产后出血。本研究旨在回顾检查 OT 与 PPD 之间潜在关系的文献的质量和可靠性,以确定是否有足够的数据来可靠评估这些关系的强度。我们于 2018 年 12 月使用五个数据库(PubMed、Web of Science、Embase、PsycInfo 和 CINAHL)进行了文献检索。使用纽卡斯尔-渥太华质量评估量表和 Cochrane 协作组评估偏倚风险的工具,适当地识别、选择和评估合格研究。有 16 项研究被纳入分析,并分为两类:内源性 OT 与 PPD 的相关性和合成 OT 与 PPD 的给药。抑郁症状主要使用爱丁堡产后抑郁量表进行测量。OT 水平主要在血浆中测量,尽管实验室方法和混杂因素(主要是母乳喂养)的控制存在差异。在 12 项专注于内源性催产素的研究中,有 8 项研究表明血浆 OT 水平与抑郁症状呈负相关。由于当前证据的异质性和研究数量较少(n = 4),我们无法根据当前证据得出关于静脉内合成催产素与产后抑郁症之间关系的任何结论。考虑到当前文献的局限性以及当前临床应用合成 OT 的流行程度,我们强烈建议进行严格的研究,以检查合成 OT 暴露对 PPD 的影响,同时继续努力定义内源性 OT 和 PPD 之间的关系。